Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.
about
Monitoring multiple myeloma by quantification of recurrent mutations in serum.Utilizing next-generation sequencing in the management of multiple myeloma.Cell-free DNA - Minimally invasive marker of hematological malignancies.Circulating tumour DNA analysis in multiple myeloma.Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?
P2860
Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Circulating tumour DNA analysi ...... th disease relapse in myeloma.
@en
type
label
Circulating tumour DNA analysi ...... th disease relapse in myeloma.
@en
prefLabel
Circulating tumour DNA analysi ...... th disease relapse in myeloma.
@en
P2093
P2860
P356
P1433
P1476
Circulating tumour DNA analysi ...... th disease relapse in myeloma.
@en
P2093
A Marziali
D Broemeling
M Ramachandran
P2860
P2888
P304
P356
10.1038/LEU.2016.366
P577
2016-11-30T00:00:00Z
P6179
1040410103